IL4 and myeloid sarcoma: Korsen et al., isolated PMBCs from healthy donors, finding significant changes in IL-4 secretion but not TNF-α and IFN-γ secretion with CLD exposure, which might be of therapeutic benefit for identifying MS patients for CLD treatment [8].